Literature DB >> 4633000

[Studies on the prognostic significance of the "stroma reactivity" to malignant melanoma. II. Inflammatory infiltration and prognosis].

F Weidner, O P Hornstein.   

Abstract

Entities:  

Mesh:

Year:  1973        PMID: 4633000

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Pathol Anat        ISSN: 0042-6423


× No keyword cloud information.
  8 in total

Review 1.  [The immunology of malignant melanoma (author's transl)].

Authors:  G Schieferstein
Journal:  Klin Wochenschr       Date:  1978-03-15

2.  [Comparative autoradiographic study on the stroma reaction in melanoma and basal cell epithelioma (author's transl)].

Authors:  H Pullmann; G K Steigleder
Journal:  Arch Dermatol Forsch       Date:  1974

3.  A study of cellular inflammatory reaction in human malignant melanoma, using in vitro-labelling techniques with h3-thymidine.

Authors:  H Pullmann; G K Steigleder
Journal:  Arch Dermatol Forsch       Date:  1974-04-29

4.  Immunity in tumours of the skin. Studies on cell-mediated immune reactions.

Authors:  C L Meneghini; G Angelini; E Bonifazi
Journal:  Arch Dermatol Forsch       Date:  1975

Review 5.  Relationship of tumor leucocytic infiltration to host defense mechanisms and prognosis.

Authors:  J W Kreider; G L Bartlett; B L Butkiewicz
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

6.  Increase of melanocytes around malignant melanoma.

Authors:  E Paul; E Gernand
Journal:  Arch Dermatol Forsch       Date:  1975-07-18

7.  The pattern of the mononuclear infiltrate as a prognostic parameter in flat superficial spreading melanomas.

Authors:  E B Bröcker; G Kolde; D Steinhausen; A Peters; E Macher
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

8.  Comparative histological studies of regional lymph nodes of 201 melanoma patients. (Microscopic features in relation to individual age, site, and metastatic spread).

Authors:  F Weidner
Journal:  Arch Dermatol Res       Date:  1979-10       Impact factor: 3.017

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.